8-chlorotheophylline

8-Chlorotheophylline

8-Chlorotheophylline

Chemical compound


8-Chlorotheophylline, also known as 1,3-dimethyl-8-chloroxanthine, is a stimulant drug of the xanthine chemical class, with physiological effects similar to caffeine.[1] Its main use is in combination (salt) with diphenhydramine in the antiemetic dimenhydrinate (Dramamine). Diphenhydramine reduces nausea but causes drowsiness, and the stimulant properties of 8-Chlorotheophylline help reduce that side effect.[2]

Quick Facts Clinical data, Routes ofadministration ...

Despite being classified as a xanthine stimulant, 8-chlorotheophylline can generally not produce any locomotor activity above control in mice and does not appear to cross the blood-brain barrier well.[citation needed]

The 8-chloro modification is not selected for pharmacological properties; instead, it was to raise the acidity of the xanthine amine group enough to form a co-salt with diphenhydramine.[2]

The drug is also sold in combination with promethazine, again as a salt.[3]


References

  1. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (May 1981). "Adenosine receptors and behavioral actions of methylxanthines". Proceedings of the National Academy of Sciences of the United States of America. 78 (5): 3260–4. Bibcode:1981PNAS...78.3260S. doi:10.1073/pnas.78.5.3260. PMC 319541. PMID 6265942.
  2. Cusic JW (3 June 1949). "Note on the Chemistry of Dramamine". Science. 109 (2840): 574. doi:10.1126/science.109.2840.574.a. PMID 17743285. S2CID 239515706.
  3. https://www.ebi.ac.uk/chebi/searchId.do?chebiId=8461 "The anti-emetic action of both the hydrochloride and the teoclate (8-chlorotheophylline) salts is used for the prevention of nausea in cases of motion sickness and post-operative vomiting."

Share this article:

This article uses material from the Wikipedia article 8-chlorotheophylline, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.